EUCTR2010-022036-36-IT进行中（未招募）1 期
A Phase 1 trial of pf-03084014 in patients with advanced solid tumor malignancy and t-cell acute lymphoblastic leukemia/lymphoblastic lymphoma - ND
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients with acute T-ALL/LBL that are refractory/resistant to current treatment options or for which no standard therapy is available.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Prior treatment with a gamma secretase inhibitor or an anti-Notch receptor antibody for treatment of cancer
研究者
相似试验
进行中（未招募）
不适用
A pilot Phase II study of PHA-739358 in patients with Chronic Myeloid Leukemia relapsing on Gleevec or c-ABL therapy - NDTreatment of Chronic Myeloid LeukemiaMedDRA version: 9.1Level: LLTClassification code 10009013Term: Chronic myeloid leukaemiaEUCTR2006-006881-40-ITERVIANO MEDICAL SCIENCES16
已完成
1 期
A Trial In Patients With Advanced Cancer And LeukemiaNeoplasms by Histologic TypeNCT00878189Pfizer72
进行中（未招募）
1 期
_Adult patients with Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and SunitinibMedDRA version: 18.0Level: LLTClassification code 10062427Term: Gastrointestinal stromal tumorSystem Organ Class: 100000004864EUCTR2013-000283-28-FRInstitut Bergonié63
已完成
2 期
DP13 * A Phase II Study in Patients with Primary Aldosteronism to Evaluate the Efficacy, Safety and Tolerability of the Aldosterone Synthase Inhibitor, DP13, over an 8-week Treatment PeriodHormonal diseasesPrimary AldosteronismNL-OMON54894DAMIAN Pharma AG15
未知
3 期
Confirmatory Study for AD-810N in Patients with Parkinsonism in Dementia with Lewy Bodies.JPRN-jRCT2080222787Sumitomo Dainippon Pharma Co., Ltd.300